A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations

Synaptojanin1 (Synj1) is a phosphoinositide phosphatase, important in clathrin uncoating during endocytosis of presynaptic vesicles. It was identified as a potential drug target for Alzheimer’s disease, Down syndrome, and TBC1D24-associated epilepsy, while also loss-of-function mutations in Synj1 ar...

Full description

Bibliographic Details
Main Authors: Jone Paesmans, Ella Martin, Babette Deckers, Marjolijn Berghmans, Ritika Sethi, Yannick Loeys, Els Pardon, Jan Steyaert, Patrik Verstreken, Christian Galicia, Wim Versées
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2020-12-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/64922
_version_ 1797991888057270272
author Jone Paesmans
Ella Martin
Babette Deckers
Marjolijn Berghmans
Ritika Sethi
Yannick Loeys
Els Pardon
Jan Steyaert
Patrik Verstreken
Christian Galicia
Wim Versées
author_facet Jone Paesmans
Ella Martin
Babette Deckers
Marjolijn Berghmans
Ritika Sethi
Yannick Loeys
Els Pardon
Jan Steyaert
Patrik Verstreken
Christian Galicia
Wim Versées
author_sort Jone Paesmans
collection DOAJ
description Synaptojanin1 (Synj1) is a phosphoinositide phosphatase, important in clathrin uncoating during endocytosis of presynaptic vesicles. It was identified as a potential drug target for Alzheimer’s disease, Down syndrome, and TBC1D24-associated epilepsy, while also loss-of-function mutations in Synj1 are associated with epilepsy and Parkinson’s disease. Despite its involvement in a range of disorders, structural, and detailed mechanistic information regarding the enzyme is lacking. Here, we report the crystal structure of the 5-phosphatase domain of Synj1. Moreover, we also present a structure of this domain bound to the substrate diC8-PI(3,4,5)P3, providing the first image of a 5-phosphatase with a trapped substrate in its active site. Together with an analysis of the contribution of the different inositide phosphate groups to catalysis, these structures provide new insights in the Synj1 mechanism. Finally, we analysed the effect of three clinical missense mutations (Y793C, R800C, Y849C) on catalysis, unveiling the molecular mechanisms underlying Synj1-associated disease.
first_indexed 2024-04-11T08:59:32Z
format Article
id doaj.art-7af11ac4f55145eba6933fc35aa0a442
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-11T08:59:32Z
publishDate 2020-12-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-7af11ac4f55145eba6933fc35aa0a4422022-12-22T04:32:49ZengeLife Sciences Publications LtdeLife2050-084X2020-12-01910.7554/eLife.64922A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutationsJone Paesmans0https://orcid.org/0000-0002-3292-4609Ella Martin1https://orcid.org/0000-0002-9607-7074Babette Deckers2https://orcid.org/0000-0002-3855-4776Marjolijn Berghmans3https://orcid.org/0000-0002-8699-6915Ritika Sethi4Yannick Loeys5Els Pardon6https://orcid.org/0000-0002-2466-0172Jan Steyaert7https://orcid.org/0000-0002-3825-874XPatrik Verstreken8Christian Galicia9https://orcid.org/0000-0001-6080-7533Wim Versées10https://orcid.org/0000-0002-4695-696XVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium; KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumVIB-VUB Center for Structural Biology, Brussels, Belgium; Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, BelgiumSynaptojanin1 (Synj1) is a phosphoinositide phosphatase, important in clathrin uncoating during endocytosis of presynaptic vesicles. It was identified as a potential drug target for Alzheimer’s disease, Down syndrome, and TBC1D24-associated epilepsy, while also loss-of-function mutations in Synj1 are associated with epilepsy and Parkinson’s disease. Despite its involvement in a range of disorders, structural, and detailed mechanistic information regarding the enzyme is lacking. Here, we report the crystal structure of the 5-phosphatase domain of Synj1. Moreover, we also present a structure of this domain bound to the substrate diC8-PI(3,4,5)P3, providing the first image of a 5-phosphatase with a trapped substrate in its active site. Together with an analysis of the contribution of the different inositide phosphate groups to catalysis, these structures provide new insights in the Synj1 mechanism. Finally, we analysed the effect of three clinical missense mutations (Y793C, R800C, Y849C) on catalysis, unveiling the molecular mechanisms underlying Synj1-associated disease.https://elifesciences.org/articles/64922inositol polyphosphate 5-phosphatasecatalytic mechanismenzyme-substrate complexepilepsyphosphoinositideParkinson's disease
spellingShingle Jone Paesmans
Ella Martin
Babette Deckers
Marjolijn Berghmans
Ritika Sethi
Yannick Loeys
Els Pardon
Jan Steyaert
Patrik Verstreken
Christian Galicia
Wim Versées
A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
eLife
inositol polyphosphate 5-phosphatase
catalytic mechanism
enzyme-substrate complex
epilepsy
phosphoinositide
Parkinson's disease
title A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
title_full A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
title_fullStr A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
title_full_unstemmed A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
title_short A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
title_sort structure of substrate bound synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
topic inositol polyphosphate 5-phosphatase
catalytic mechanism
enzyme-substrate complex
epilepsy
phosphoinositide
Parkinson's disease
url https://elifesciences.org/articles/64922
work_keys_str_mv AT jonepaesmans astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT ellamartin astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT babettedeckers astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT marjolijnberghmans astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT ritikasethi astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT yannickloeys astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT elspardon astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT jansteyaert astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT patrikverstreken astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT christiangalicia astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT wimversees astructureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT jonepaesmans structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT ellamartin structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT babettedeckers structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT marjolijnberghmans structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT ritikasethi structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT yannickloeys structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT elspardon structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT jansteyaert structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT patrikverstreken structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT christiangalicia structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations
AT wimversees structureofsubstrateboundsynaptojanin1providesnewinsightsinitsmechanismandtheeffectofdiseasemutations